Mitchell Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-17,377
| Closed | -$1.17M | – | 118 |
|
|
2023
Q4 | $1.17M | Sell |
17,377
-715
| -4% | -$48.2K | 0.25% | 85 |
|
|
2023
Q3 | $1.23M | Sell |
18,092
-121
| -0.7% | -$8.19K | 0.29% | 81 |
|
|
2023
Q2 | $1.3M | Buy |
18,213
+852
| +5% | +$61K | 0.3% | 83 |
|
|
2023
Q1 | $1.21M | Buy |
17,361
+67
| +0.4% | +$4.65K | 0.3% | 87 |
|
|
2022
Q4 | $1.17M | Buy |
17,294
+41
| +0.2% | +$2.78K | 0.32% | 89 |
|
|
2022
Q3 | $946K | Sell |
17,253
-507
| -3% | -$27.8K | 0.27% | 94 |
|
|
2022
Q2 | $1.17M | Buy |
17,760
+194
| +1% | +$12.8K | 0.33% | 83 |
|
|
2022
Q1 | $1.17M | Buy |
17,566
+967
| +6% | +$64.1K | 0.26% | 95 |
|
|
2021
Q4 | $967K | Buy |
16,599
+95
| +0.6% | +$5.53K | 0.2% | 105 |
|
|
2021
Q3 | $991K | Buy |
16,504
+263
| +2% | +$15.8K | 0.22% | 111 |
|
|
2021
Q2 | $973K | Buy |
16,241
+1,236
| +8% | +$74K | 0.21% | 116 |
|
|
2021
Q1 | $746K | Buy |
15,005
+2,768
| +23% | +$138K | 0.18% | 123 |
|
|
2020
Q4 | $612K | Sell |
12,237
-10,068
| -45% | -$504K | 0.15% | 119 |
|
|
2020
Q3 | $1.22M | Sell |
22,305
-226
| -1% | -$12.4K | 0.35% | 82 |
|
|
2020
Q2 | $1.19M | Sell |
22,531
-2,212
| -9% | -$117K | 0.38% | 79 |
|
|
2020
Q1 | $1.11M | Buy |
24,743
+2,417
| +11% | +$108K | 0.43% | 74 |
|
|
2019
Q4 | $1.11M | Sell |
22,326
-320
| -1% | -$16K | 0.35% | 77 |
|
|
2019
Q3 | $1.01M | Buy |
22,646
+3,153
| +16% | +$140K | 0.34% | 83 |
|
|
2019
Q2 | $805K | Buy |
19,493
+320
| +2% | +$13.2K | 0.27% | 88 |
|
|
2019
Q1 | $775K | Sell |
19,173
-1,178
| -6% | -$47.6K | 0.27% | 84 |
|
|
2018
Q4 | $773K | Sell |
20,351
-24
| -0.1% | -$912 | 0.33% | 70 |
|
|
2018
Q3 | $806K | Buy |
20,375
+3,353
| +20% | +$133K | 0.26% | 74 |
|
|
2018
Q2 | $598K | Buy |
17,022
+3,919
| +30% | +$138K | 0.22% | 75 |
|
|
2018
Q1 | $458K | Buy |
13,103
+5,103
| +64% | +$178K | 0.17% | 76 |
|
|
2017
Q4 | $278K | Buy |
8,000
+1,780
| +29% | +$61.9K | 0.1% | 77 |
|
|
2017
Q3 | $211K | Buy |
+6,220
| New | +$211K | 0.08% | 63 |
|